Medical Research
About
The John Curtin School of Medical Research is amongst Australia's leading research institutes and performs fundamental research that tackles real-world health challenges whilst nurturing the next generation of medical researchers.
The institute was established in 1948 as a founding school of the Australian National University. We are renowned for pioneering medical breakthroughs. With a legacy of three Nobel Laureates and a league of exceptional researchers, our focus is collaborative, innovative research tackling diseases that encompass cancer, infectious diseases and neurological conditions using our expertise in neuroscience, genomics, immunology, and cancer discovery science.
Facilities
The Advanced Imaging Precinct includes the Centre for Advanced Microscopy (CAM) and the National Laboratory for X-ray Micro Computed Tomography (CTLab).
The ANU Centre for Therapeutic Discovery (ACTD) is a state-of-the-art high-throughput screening facility for biomarker and therapeutic discovery.
We are committed to helping researchers be at the forefront of scientific discovery in the fields of genetics, genomics, and molecular biosciences.
The CHASM Facility offers cutting edge instrumentation and expertise in high dimensional flow cytometry cell analysis, cell sorting, histology, automated immunochemistry, in vivo optical imaging, low dose micro-CT and Spatial Multiomics services.
The National Therapeutic mRNA Platform (NTRP) is an open-access sovereign platform for the design, testing and optimisation of novel therapeutic mRNA candidates.
News
The National Centre for Indigenous Genomics is working with Indigenous communities on the ethical and respectful use of the stories held within DNA.
A widely available and affordable drug has shown to be effective in treating seriously ill COVID-19 patients, according to a new study.
A new discovery made by ANU researchers could lead to smarter, more effective treatments for Hodgkin Lymphoma, a common blood cancer.
ANU researchers and global partners are launching a clinical trial to improve treatment for Kaposi sarcoma, one of the most common and deadly cancers in sub-Saharan Africa.
Vijay Bhoopalan was one of four ANU emerging researchers to be recognised and celebrated for their outstanding early-career impact in health research and innovation in the ACT.
Emerging researchers from ANU have been selected in the 2025 CHARM Rising Star Awards, celebrating their outstanding early-career impact in health research and innovation in the ACT.